| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,504 |
33,681 |
$1.49M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,245 |
6,157 |
$457K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,005 |
5,643 |
$421K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
28,307 |
11,507 |
$320K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,147 |
4,099 |
$309K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,817 |
2,592 |
$203K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,648 |
2,442 |
$97K |
| 99463 |
|
728 |
721 |
$80K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,070 |
1,056 |
$65K |
| 90461 |
|
8,294 |
7,145 |
$48K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,632 |
4,781 |
$46K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
419 |
395 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,846 |
1,761 |
$41K |
| 99429 |
|
1,049 |
1,044 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,225 |
2,128 |
$27K |
| 99383 |
|
280 |
278 |
$23K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
395 |
391 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
728 |
703 |
$15K |
| 99382 |
|
167 |
165 |
$15K |
| 90670 |
|
3,351 |
3,332 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
130 |
125 |
$10K |
| 0071A |
|
183 |
183 |
$7K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
291 |
286 |
$7K |
| 0072A |
|
151 |
151 |
$6K |
| 0081A |
|
155 |
152 |
$6K |
| 96160 |
|
2,664 |
2,644 |
$5K |
| 87807 |
|
581 |
518 |
$5K |
| 90710 |
|
1,483 |
1,473 |
$3K |
| 99381 |
|
40 |
38 |
$3K |
| 0082A |
|
76 |
73 |
$3K |
| 81002 |
|
1,171 |
1,073 |
$3K |
| 90680 |
|
2,277 |
2,265 |
$3K |
| 0054A |
|
52 |
52 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
123 |
123 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
159 |
139 |
$2K |
| 83655 |
|
183 |
182 |
$1K |
| 99050 |
|
32 |
32 |
$1K |
| 90698 |
|
1,285 |
1,278 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
91 |
88 |
$1K |
| 0052A |
|
31 |
31 |
$1K |
| 90633 |
|
2,350 |
2,331 |
$1K |
| 99499 |
|
16 |
16 |
$1K |
| 0051A |
|
24 |
24 |
$880.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
90 |
90 |
$728.38 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$671.94 |
| 90647 |
|
618 |
611 |
$590.73 |
| 90686 |
|
2,681 |
2,674 |
$546.97 |
| 90700 |
|
1,092 |
1,080 |
$422.10 |
| 90723 |
|
2,338 |
2,319 |
$390.63 |
| 90648 |
|
2,807 |
2,787 |
$304.21 |
| 90685 |
|
154 |
149 |
$294.24 |
| 90734 |
|
969 |
966 |
$254.47 |
| 90716 |
|
527 |
525 |
$245.11 |
| 96380 |
|
12 |
12 |
$229.08 |
| 90651 |
|
701 |
695 |
$177.14 |
| 90707 |
|
513 |
511 |
$94.23 |
| 90696 |
|
714 |
710 |
$57.23 |
| 86308 |
|
12 |
12 |
$53.76 |
| 90715 |
|
433 |
432 |
$35.76 |
| 94760 |
|
32 |
29 |
$6.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$3.12 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
42 |
42 |
$2.08 |
| 90677 |
|
1,255 |
1,235 |
$0.66 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
1,670 |
1,640 |
$0.43 |
| 90681 |
|
760 |
751 |
$0.25 |
| 91307 |
|
485 |
463 |
$0.15 |
| 91308 |
|
272 |
251 |
$0.14 |
| 90620 |
|
359 |
359 |
$0.10 |
| 91305 |
|
157 |
151 |
$0.10 |
| 90621 |
|
14 |
14 |
$0.00 |
| 90744 |
|
45 |
45 |
$0.00 |